Ubm emea pharma events reach over 100,000 attendees in AsiaCPhI shows in Japan, China, South East Asia, India and Korea to drive growth in 2017 Amsterdam, 4th July 2017:
Ubm emea announces that its CPhI events, the largest dedicated pharma exhibition series in the world, will welcome over 100,000 attendees to Asia in 2017. UBM hosts five CPhI events in the region – including industry flagships CPhI & P-MEC China, CPhI & P-MEC India, and CPhI Japan, as well as high growth events, CPhI South East Asia and CPhI Korea.
UBM’s strategy in Asia is to serve the largest pharma industries by creating locally tailored events that maximize opportunities for exhibiting companies to meet with potential partners, both from the domestic market, but also new customers regionally and internationally. These events act as a hub to help businesses grow in new markets, whilst also providing bespoke content programmes, with new learnings, practical solutions, industry trends and developments.
CPhI South East Asia closed its sixth edition in late March 2017 with over 5,000 attendees and 260 exhibitors. The 2017 event